Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Monthly presentations of the latest, original scientific data from randomized phase III trials in oncology, or from phase II trials which demonstrate remarkable therapeutic benefit, scientific insight or progress in an area of unmet need.
The ESMO Virtual Plenaries are freely available to all healthcare professionals working in Oncology. Slides and webcasts from ESMO Virtual Plenaries are open to all, ESMO Members and free ESMO Account holders, according to the presenters' agreement to release them.
The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.
ESMO would like to thank the following partner for its support
Presenter: Philippe Moreau, France; Discussant: Francesca Gay, Italy
Presenter: Luis Paz-Ares, Spain; Discussant: Martin Reck, Germany
Presenter: Ignace Vergote, Belgium; Discussant: Amit Oza, Canada
Presenter: Andrew Tutt, UK; Discussant: Mark Robson, USA
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
